Free Trial

Bio-Rad Laboratories (BIO) Competitors

Bio-Rad Laboratories logo
$262.42 +9.35 (+3.69%)
As of 11:15 AM Eastern

BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and A

Should you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.

Bio-Rad Laboratories vs. Its Competitors

Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad Laboratories$2.57B2.78-$1.84B-$76.20-3.44
Mettler-Toledo International$3.87B6.74$863.14M$40.1031.33

Mettler-Toledo International has a net margin of 22.17% compared to Bio-Rad Laboratories' net margin of -85.16%. Bio-Rad Laboratories' return on equity of 4.32% beat Mettler-Toledo International's return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Rad Laboratories-85.16% 4.32% 3.03%
Mettler-Toledo International 22.17%-556.22%26.27%

Bio-Rad Laboratories has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500.

Bio-Rad Laboratories presently has a consensus target price of $324.25, indicating a potential upside of 23.56%. Mettler-Toledo International has a consensus target price of $1,280.90, indicating a potential upside of 1.94%. Given Bio-Rad Laboratories' stronger consensus rating and higher probable upside, research analysts plainly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Rad Laboratories
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Mettler-Toledo International
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45

65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 17.1% of Bio-Rad Laboratories shares are owned by company insiders. Comparatively, 1.9% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Mettler-Toledo International had 16 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 19 mentions for Mettler-Toledo International and 3 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 1.35 beat Bio-Rad Laboratories' score of 1.14 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bio-Rad Laboratories
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mettler-Toledo International
13 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 12 of the 16 factors compared between the two stocks.

Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIO vs. The Competition

MetricBio-Rad LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$7.14B$10.54B$5.59B$20.55B
Dividend YieldN/A2.09%5.25%3.74%
P/E Ratio-3.4416.5927.5428.00
Price / Sales2.7831.46415.8340.51
Price / Cash24.1322.7937.0622.25
Price / Book1.123.768.104.60
Net Income-$1.84B$235.43M$3.17B$982.91M
7 Day Performance4.32%3.69%3.33%0.78%
1 Month Performance13.92%3.98%3.54%4.24%
1 Year Performance-6.43%-10.14%33.62%14.43%

Bio-Rad Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIO
Bio-Rad Laboratories
4.846 of 5 stars
$262.42
+3.7%
$324.25
+23.6%
-8.0%$7.14B$2.57B-3.447,700Positive News
MTD
Mettler-Toledo International
4.333 of 5 stars
$1,175.56
-0.8%
$1,300.36
+10.6%
-6.7%$24.43B$3.87B29.3218,000Positive News
Analyst Forecast
WAT
Waters
4.1154 of 5 stars
$349.93
-0.7%
$388.00
+10.9%
+23.8%$20.82B$2.96B31.758,200Trending News
ILMN
Illumina
4.895 of 5 stars
$95.41
+0.7%
$127.39
+33.5%
-8.7%$15.10B$4.37B-15.729,030Positive News
Analyst Forecast
Gap Down
TECH
Bio-Techne
4.954 of 5 stars
$51.45
-0.8%
$72.00
+39.9%
-26.2%$8.07B$1.16B62.743,100Analyst Forecast
CRL
Charles River Laboratories International
4.1653 of 5 stars
$151.64
+1.1%
$171.85
+13.3%
-21.4%$7.45B$4.05B-233.2920,100News Coverage
Positive News
Analyst Upgrade
Gap Up
BRKR
Bruker
4.7502 of 5 stars
$41.20
-1.4%
$52.89
+28.4%
-31.2%$6.24B$3.45B79.2311,396
PACB
Pacific Biosciences of California
2.5008 of 5 stars
$1.24
-3.9%
$2.06
+66.2%
+13.0%$372.10M$154.01M-0.44730Gap Down
HBIO
Harvard Bioscience
4.152 of 5 stars
$0.44
-4.3%
$3.00
+576.0%
-83.5%$19.62M$94.14M-0.34490Trending News
TMO
Thermo Fisher Scientific
4.9931 of 5 stars
$405.83
-0.6%
$604.05
+48.8%
-21.1%$153.20B$42.88B23.80125,000Positive News
Analyst Forecast
A
Agilent Technologies
4.8368 of 5 stars
$118.06
-0.9%
$140.92
+19.4%
-3.1%$33.54B$6.51B29.1518,100Positive News
Analyst Forecast

Related Companies and Tools


This page (NYSE:BIO) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners